WorldQuant Millennium Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.5M | Buy |
501,148
+263,014
| +110% | +$14.5M | 0.14% | 174 |
|
2025
Q1 | $16.8M | Sell |
238,134
-39,984
| -14% | -$2.83M | 0.11% | 197 |
|
2024
Q4 | $18.3M | Buy |
278,118
+214,546
| +337% | +$14.1M | 0.12% | 191 |
|
2024
Q3 | $4.47M | Buy |
+63,572
| New | +$4.47M | 0.03% | 290 |
|
2023
Q1 | – | Sell |
-22,872
| Closed | -$2.37M | – | 357 |
|
2022
Q4 | $2.37M | Sell |
22,872
-154,461
| -87% | -$16M | 0.05% | 254 |
|
2022
Q3 | $15M | Buy |
177,333
+92,275
| +108% | +$7.82M | 0.37% | 92 |
|
2022
Q2 | $7.05M | Buy |
85,058
+60,231
| +243% | +$4.99M | 0.2% | 154 |
|
2022
Q1 | $1.91M | Sell |
24,827
-35,024
| -59% | -$2.7M | 0.05% | 250 |
|
2021
Q4 | $5.29M | Sell |
59,851
-23,150
| -28% | -$2.05M | 0.11% | 215 |
|
2021
Q3 | $6.42M | Buy |
+83,001
| New | +$6.42M | 0.14% | 187 |
|
2020
Q4 | – | Sell |
-32,717
| Closed | -$2.49M | – | 348 |
|
2020
Q3 | $2.49M | Sell |
32,717
-58,915
| -64% | -$4.48M | 0.06% | 271 |
|
2020
Q2 | $11.3M | Sell |
91,632
-11,803
| -11% | -$1.46M | 0.26% | 132 |
|
2020
Q1 | $8.74M | Buy |
103,435
+2,759
| +3% | +$233K | 0.21% | 142 |
|
2019
Q4 | $8.51M | Sell |
100,676
-19,771
| -16% | -$1.67M | 0.16% | 174 |
|
2019
Q3 | $8.12M | Sell |
120,447
-11,658
| -9% | -$786K | 0.16% | 181 |
|
2019
Q2 | $11.3M | Buy |
132,105
+19,398
| +17% | +$1.66M | 0.22% | 142 |
|
2019
Q1 | $10M | Sell |
112,707
-34,064
| -23% | -$3.03M | 0.24% | 135 |
|
2018
Q4 | $12.5M | Sell |
146,771
-32,523
| -18% | -$2.77M | 0.37% | 103 |
|
2018
Q3 | $17.4M | Buy |
179,294
+39,532
| +28% | +$3.83M | 0.58% | 60 |
|
2018
Q2 | $13.2M | Buy |
+139,762
| New | +$13.2M | 0.51% | 71 |
|